Survivor Keeps Faith While UTMB Leads her through Recovery, Reconstruction October 17, 2022, 09:39 AM by Living Magazine This feature first ran as a cover story in the October 2022 issue of the Bay Area-Friendswood edition of Living Magazine. *This link will open a new page* New Surgeon Brings Expertise in Thoracic Oncology October 13, 2022, 15:42 PM by UTMB Faculty Group Practice Team When a patient is diagnosed with lung cancer, a multidisciplinary team approach is necessary to determine the best path forward – whether the patient needs radiation, chemotherapy, surgery, or a combination of these treatments. Dr. Shokrzadeh Awarded Grant to Study Family Planning Among Physician Trainees & Faculty October 3, 2022, 15:04 PM by UTMB Surgery UTMB vascular surgeon Christine Shokrzadeh, MD, recently received a grant from the Eastern Vascular Society to study family planning in surgical trainees and young faculty. Jong Lee, M.D., Named Chief of Staff for Burns at Shriners Children's Texas October 3, 2022, 09:21 AM by Shriners Children's Texas Burn Care Jong Lee, M.D., a 21-year veteran of caring for children with acute burns at Shriners Children’s Texas, has been named the hospital’s chief of staff for burns and the Jim and Susan Clawson Endowed Chair. Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing October 3, 2022, 08:57 AM by Source: Provectus Biopharmaceuticals Inc. Drs. El Ayadi and Jay plan to examine the safety of topically-applied, multi-dosed RBS over the wound healing periods of inflammation and cellular proliferation, determine the efficacy of RBS in a pre-clinical model of wound healing, and elucidate a spatiotemporal immune activation signature over wound healing time in a large animal model of burn and full-thickness cutaneous trauma. « 11 12 13 14 15 16 17 18 19 20 » Categories Awards & Accolades Breast Oncology Burn, Trauma, & Acute Care Cancer Cardiovascular & Thoracic Colorectal Surgery Emerging Tech Foregut Surgery Gastrointestinal Surgery General Surgery Grand Rounds Lectures LSTAR Minimally-Invasive Surgery Oral & Maxillofacial Surgery Past Events Pediatric Surgery Plastic Surgery Research Resident News Residents Robotic Surgery Surgical Oncology Surgical Quality Transplant Surgery Urology Vascular Surgery Visiting Lecturers Women's Health Winter 2024 Newsletter Fall 2023 Newsletter Summer 2023 Newsletter Spring 2024 Newsletter
Survivor Keeps Faith While UTMB Leads her through Recovery, Reconstruction October 17, 2022, 09:39 AM by Living Magazine This feature first ran as a cover story in the October 2022 issue of the Bay Area-Friendswood edition of Living Magazine. *This link will open a new page*
New Surgeon Brings Expertise in Thoracic Oncology October 13, 2022, 15:42 PM by UTMB Faculty Group Practice Team When a patient is diagnosed with lung cancer, a multidisciplinary team approach is necessary to determine the best path forward – whether the patient needs radiation, chemotherapy, surgery, or a combination of these treatments.
Dr. Shokrzadeh Awarded Grant to Study Family Planning Among Physician Trainees & Faculty October 3, 2022, 15:04 PM by UTMB Surgery UTMB vascular surgeon Christine Shokrzadeh, MD, recently received a grant from the Eastern Vascular Society to study family planning in surgical trainees and young faculty.
Jong Lee, M.D., Named Chief of Staff for Burns at Shriners Children's Texas October 3, 2022, 09:21 AM by Shriners Children's Texas Burn Care Jong Lee, M.D., a 21-year veteran of caring for children with acute burns at Shriners Children’s Texas, has been named the hospital’s chief of staff for burns and the Jim and Susan Clawson Endowed Chair.
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing October 3, 2022, 08:57 AM by Source: Provectus Biopharmaceuticals Inc. Drs. El Ayadi and Jay plan to examine the safety of topically-applied, multi-dosed RBS over the wound healing periods of inflammation and cellular proliferation, determine the efficacy of RBS in a pre-clinical model of wound healing, and elucidate a spatiotemporal immune activation signature over wound healing time in a large animal model of burn and full-thickness cutaneous trauma.